EMILY WALL: Open Payments
NPI 1497523609 · CHERAW, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,589 in 87 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,875 · 2025 $1,589
Food & beverage: $1,589
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $316 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $208 |
| AstraZeneca Pharmaceuticals LP | 9 | $190 |
| Novo Nordisk Inc | 11 | $182 |
| Corcept Therapeutics | 7 | $137 |
| PFIZER INC. | 5 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $67 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
Products named: CAPLYTA, VRAYLAR, Korlym, AIRSUPRA, UBRELVY, Ozempic, LEQVIO, FARXIGA.
Industry payments across SC — which companies pay providers there.
